Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/1999
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054454A1 Mutants of the mycobacterium species and use of the same for screening for antibiotics vectors
10/28/1999WO1999054449A2 Dyskerine and dyskerine coding dna molecule, vectors containing the same, antibodies against dyskerin and utilization of said elements
10/28/1999WO1999054448A2 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054446A2 Human nucleic acid sequences which are overexpressed in normal pancreas tissue
10/28/1999WO1999054442A1 Protein phosphatase methylesterase dna
10/28/1999WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999WO1999054439A1 Isolation and purging of cells by means of osmotic pressure
10/28/1999WO1999054435A2 Immortalised cell lines derived from normal human skin tissues
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999WO1999053762A1 A method for efficient and highly selective control of microorganisms
10/28/1999WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999WO1999041379A9 Members of the d52 gene family
10/28/1999WO1999041378A9 Members of the d52 gene family
10/28/1999WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999WO1999028446A3 Branched chain amino acid biosynthetic enzymes
10/28/1999WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999WO1999024463A3 Signal peptide-containing proteins
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999DE19817118C1 New nucleic acid encoding human dyskerin, for diagnosis, treatment and prevention of dyskeratosis congenita and for stabilizing chromosomes
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2330839A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same
10/28/1999CA2328967A1 A method for efficient and highly selective control of microorganisms
10/28/1999CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999CA2326067A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999CA2325604A1 Mutants of the mycobacterium species and the use thereof for screening for antibiotic vectors
10/28/1999CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999CA2324297A1 Sh2 domain-containing peptides
10/28/1999CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/27/1999EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase
10/27/1999EP0952221A2 L-Glutamic acid-producing bacterium and method for producing L-glutamic acid
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0952213A2 Process for inducing an immune response mediated by NK-cells
10/27/1999EP0952158A1 Modified methylotrophic p. pastoris yeast which secretes human groth hormone
10/27/1999EP0951557A1 Methods for generating and screening novel metabolic pathways
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999EP0951549A1 Mammalian chemokines
10/27/1999EP0951545A2 Human gtp-binding proteins
10/27/1999EP0951543A1 Human glycine transporter
10/27/1999EP0951538A2 PARTIAL SEQUENCES OF PURINE BIOSYNTHESIS GENES FROM $i(ASHBYA GOSSYPII) AND THEIR USE IN THE MICROBIAL RIBOFLAVIN SYNTHESIS
10/27/1999EP0951537A1 Recombinant collagen and derived proteins produced by plants, methods for obtaining them and uses
10/27/1999EP0951534A1 Nucleic acid sequence encoding beta-c-4-oxygenase from haematococcus pluvialis for the biosynthesis of astaxanthin
10/27/1999EP0951531A1 Lactic ferment comprising a particular strain of lactobacillus acidophilus and use thereof
10/27/1999EP0951530A1 Sulphur reducing bacterium and its use in biological desulphurisation processes
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0715655B1 Method of detecting and counting microorganisms
10/27/1999EP0539525B1 Vitaletheine and use in cell culture and therapy
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233285A Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria
10/27/1999CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999CN1232873A Production of spore lactic acid bacteria powder
10/27/1999CN1232872A Overproduction of riboflavin in yeast
10/27/1999CN1232628A Production process of microbial protein feed
10/27/1999CN1045997C Anti-coccidium agent composition and its preparation
10/26/1999US5973231 For transforming hosts with pesticidal protein; killing pests with host transformed to express protein
10/26/1999US5973230 Pinosylvine synthase genes
10/26/1999US5973225 Cloned and sequenced gene correlated with qualitative characteristics of duram wheat meal and bran; recombinant expression vector in host cells; microorganism transformed with vector
10/26/1999US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999US5973130 Antiproliferative/antiarthric/antidiabetic/antiallergen andantiinflammatory agents; diagnosis and treatment of acquired immuno deficiency syndrome, crohn's/addison's diseases, ulcers, osteoporsis
10/26/1999US5973119 Cyclin E genes and proteins
10/26/1999US5973118 A polypeptide which codes a trypsin inhibitor; for purification of tissue plasminogen activators
10/26/1999US5973117 Isolated and purified receptor protein endogenous to rt, bovine, or human, capable of binding a pituitary adneylate cyclase activating polypeptide (pacap) or salt, and amino acid sequences encoding it; diagnostic, e.g. of neuropathy
10/26/1999US5972902 DNA encoding human IL-6 receptor antagonist and protein encoded thereby
10/26/1999US5972708 Plasmid stabilization
10/26/1999US5972702 There also exists a need to identify the gene(s) responsible for osteopetrosis and to provide a genetic therapy for treating osteopetrosis. an object of the invention is to provide compounds that desirably influence the bone remodeling
10/26/1999US5972687 Toxin gene from Xenorhabdus nematophilus
10/26/1999US5972686 Ice nucleation active microorganism
10/26/1999US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999US5972673 Enzyme for phage resistance
10/26/1999US5972671 Fructosyl amino acid oxidase and process for producing the same
10/26/1999US5972664 Methods and compositions for synthesis of long chain poly-unsaturated fatty acids
10/26/1999US5972663 Microorganism strain that overexpresses a gene which encodes a protein directly suitable for secreting antibiotics, or other toxic substances, out of the cell, the strain also has deregulated metabolism for increased l-cysteine production
10/26/1999US5972659 Introducing into e. coli a heterologous plasmid expression vector coding for the tobacco mosaic virus protein coat and a pathogen's epitope, separating fusion protein and lowering ph to form a self-aggregated protein and hapten for vaccines
10/26/1999US5972658 DNA encoding lung growth factor variant
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972650 Can be used as vehicles for the delivery of nucleic acids that can serve as therapeutic agents and as part of vaccines designed to immunize people or animals against viral diseases.
10/26/1999US5972649 Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
10/26/1999US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999US5972644 Cyanobacterial and plant acetyl-CoA carboxylase
10/26/1999US5972642 Cultivating a strain of phaffia rhodozyma with specific oxygen transfer rate in a shake flask with biotin or desthiobiotin in the media; culturing under growth limiting conditions to increase astaxanthin production; harvesting
10/26/1999US5972638 Spraying recombinant bacteria on surface of ground, examining ground to detect visible signal formed after period of time
10/26/1999US5972614 To screen patients for sensitivity to specific drugs. the present invention also relates to the isolation of naturally occurring gene targets for pharmaceutical development.
1 ... 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 ... 1489